{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:36Z","timestamp":1793298816799,"version":"4.5.0"},"reference-count":173,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Atopic dermatitis (AD), commonly known as Eczema, is a non-communicable skin condition\nthat tends to become chronic. The deteriorating immunological abnormalities are marked by mild\nto severe erythema, severe itching, and recurrent eczematous lesions. Different pharmacological approaches\nare used to treat AD. The problem with commercial topical preparations lies in the limitation\nof skin atrophy, systemic side effects, and burning sensation that decreases patient compliance. The\ncarrier-based system promises to eliminate these shortcomings; thus, a novel approach to treating AD\nis required. Liposomes, microemulsions, solid lipid nanoparticles (SLNs), nanoemulsions, etc., have\nbeen developed recently to address this ailment. Despite extensive research in the development method\nand various techniques, it has been challenging to demonstrate the commercial feasibility of these carrier-\nbased systems, which illustrates a gap among the different research areas. Further, different soft\nwares and other tools have proliferated among biochemists as part of a cooperative approach to drug\ndiscovery. It is crucial in designing, developing, and analyzing processes in the pharmaceutical industry\nand is widely used to reduce costs, accelerate the development of biologically innovative active\ningredients, and shorten the development time. This review sheds light on the compilation of extensive\nefforts to combat this disease, the product development processes, commercial products along with\npatents in this regard, numerous options for each step of computer-aided drug design, including in silico\npharmacokinetics, pharmacodynamics, and toxicity screening or predictions that are important in\nfinding the drug-like compounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666230508121716","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:10:32Z","timestamp":1683609032000},"page":"932-960","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent Advances in Nanocarrier-based Approaches to Atopic Dermatitis\nand Emerging Trends in Drug Development and Design"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-5294","authenticated-orcid":true,"family":"Amisha","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":true,"given":"Balak Das","family":"Kurmi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-1420","authenticated-orcid":true,"given":"Amrinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1208\/s12249-021-01920-3","volume":"22","author":"Parekh K.","year":"2021","unstructured":"Parekh K.; Mehta T.A.; Dhas N.; Kumar P.; Popat A.; Emerging nanomedicines for the treatment of atopic dermatitis. AAPS Pharm Sci Tech  2021,22(2),55","journal-title":"AAPS Pharm Sci Tech"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"Boguniewicz M.","year":"2011","unstructured":"Boguniewicz M.; Leung D.Y.M.; Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev  2011,242(1),233-246","journal-title":"Immunol Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2015.06.029","volume":"137","author":"Schmitt J.","year":"2016","unstructured":"Schmitt J.; Schwarz K.; Baurecht H.; Hotze M.; F\u00f6lster-Holst R.; Rodr\u00edguez E.; Lee Y.A.E.; Franke A.; Degenhardt F.; Lieb W.; Gieger C.; Kabesch M.; N\u00f6then M.M.; Irvine A.D.; McLean W.H.I.; Deckert S.; Stephan V.; Schwarz P.; Aringer M.; Novak N.; Weidinger S.; Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol  2016,137(1),130-136","journal-title":"J Allergy Clin Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cnur.2007.06.002","volume":"42","author":"Tofte S.","year":"2007","unstructured":"Tofte S.; Atopic dermatitis. Nurs Clin North Am  2007,42(3),407-419, vi","journal-title":"Nurs Clin North Am"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/all.13059","volume":"71","author":"Zellweger F.","year":"2016","unstructured":"Zellweger F.; Eggel A.; IgE-associated allergic disorders: Recent advances in etiology, diagnosis, and treatment. Allergy  2016,71(12),1652-1661","journal-title":"Allergy"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jdv.14891","volume":"32","author":"Wollenberg A.","year":"2018","unstructured":"Wollenberg A.; Barbarot S.; Bieber T.; Christen-Zaech S.; Deleuran M.; Fink-Wagner A.; Gieler U.; Girolomoni G.; Lau S.; Muraro A.; Czarnecka-Operacz M.; Sch\u00e4fer T.; Schmid-Grendelmeier P.; Simon D.; Szalai Z.; Szepietowski J.C.; Ta\u00efeb A.; Torrelo A.; Werfel T.; Ring J.; Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol  2018,32(5),657-682","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","volume":"24","author":"Kumar M.","year":"2019","unstructured":"Kumar M.; Bishnoi R.S.; Shukla A.K.; Jain C.P.; Techniques for formulation of nanoemulsion drug delivery system: A review. Prev Nutr Food Sci  2019,24(3),225-234","journal-title":"Prev Nutr Food Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"112633","DOI":"10.1016\/j.biopha.2022.112633","volume":"147","author":"Hemrajani C.","year":"2022","unstructured":"Hemrajani C.; Negi P.; Parashar A.; Gupta G.; Jha N.K.; Singh S.K.; Chellappan D.K.; Dua K.; Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed Pharmacother  2022,147,112633","journal-title":"Biomed Pharmacother"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.sder.2012.07.002","volume":"31","author":"Eichenfield L.F.","year":"2012","unstructured":"Eichenfield L.F.; Ellis C.N.; Mancini A.J.; Paller A.S.; Simpson E.L.; Atopic dermatitis: Epidemiology and pathogenesis update. Semin Cutan Med Surg  2012,31(S3),S3-S5","journal-title":"Semin Cutan Med Surg"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"Nutten S.","year":"2015","unstructured":"Nutten S.; Atopic dermatitis: Global epidemiology and risk factors. Ann Nutr Metab  2015,66(S2),8-16","journal-title":"Ann Nutr Metab"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.iac.2021.07.005","volume":"41","author":"Saini S.","year":"2021","unstructured":"Saini S.; Pansare M.; New insights and treatments in atopic dermatitis. Immunol Allergy Clin North Am  2021,41(4),653-665","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.pcl.2019.06.008","volume":"66","author":"Saini S.","year":"2019","unstructured":"Saini S.; Pansare M.; New insights and treatments in atopic dermatitis. Pediatr Clin North Am  2019,66(5),1021-1033","journal-title":"Pediatr Clin North Am"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","volume":"36","author":"Saeki H.","year":"2009","unstructured":"Saeki H.; Furue M.; Furukawa F.; Hide M.; Ohtsuki M.; Katayama I.; Sasaki R.; Suto H.; Takehara K.; Guidelines for management of atopic dermatitis. J Dermatol  2009,36(10),563-577","journal-title":"J Dermatol"},{"key":"ref=14","unstructured":"National Library of Medicine. Clinical Trials  https:\/\/clinicaltrials.gov\/ (Accessed August 04, 2022)."},{"key":"ref=15","first-page":"132","author":"Peng G.","year":"2020","unstructured":"Peng G.; Niyonsaba F.;  Atopic Dermatitis; From to Treatment  2020,132-179","journal-title":"Atopic Dermatitis; From to Treatment"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","volume":"27","author":"Nakatsuji T.","year":"2021","unstructured":"Nakatsuji T.; Hata T.R.; Tong Y.; Cheng J.Y.; Shafiq F.; Butcher A.M.; Salem S.S.; Brinton S.L.; Rudman Spergel A.K.; Johnson K.; Jepson B.; Calatroni A.; David G.; Ramirez-Gama M.; Taylor P.; Leung D.Y.M.; Gallo R.L.; Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med  2021,27(4),700-709","journal-title":"Nat Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/cea.13820","volume":"51","author":"Yue H.","year":"2021","unstructured":"Yue H.; Umehara Y.; Trujillo-Paez J.V.; Peng G.; Nguyen H.L.T.; Chieosilapatham P.; Kiatsurayanon C.; Song P.; Okumura K.; Ogawa H.; Ikeda S.; Niyonsaba F.; Exogenous factors in the pathogenesis of atopic dermatitis: Irritants and cutaneous infections. Clin Exp Allergy  2021,51(3),382-392","journal-title":"Clin Exp Allergy"},{"key":"ref=18","first-page":"1103459","volume":"1","author":"Egawa G.","year":"2015","unstructured":"Egawa G.; Weninger, WJCB Pathogenesis of atopic dermatitis: A short review. Indian J Exp Biol  2015,1(1),1103459","journal-title":"Indian J Exp Biol"},{"key":"ref=19","first-page":"368","volume":"47","author":"Bhalaria M.K.","year":"2009","unstructured":"Bhalaria M.K.; Naik S.; Misra A.N.; Ethosomes: A novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol  2009,47(5),368-375","journal-title":"Indian J Exp Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0738-081X(01)00183-3","volume":"19","author":"Morganti P.","year":"2001","unstructured":"Morganti P.; Ruocco E.; Wolf R.; Ruocco V.; Percutaneous absorption and delivery systems33The opinions expressed herein are solely those of the writers and do not necessarily reflect the opinions of the institutions with which the writers are associated. Clin Dermatol  2001,19(4),489-501","journal-title":"Clin Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/10717544.2013.855277","volume":"22","author":"Goyal G.","year":"2015","unstructured":"Goyal G.; Garg T.; Malik B.; Chauhan G.; Rath G.; Goyal A.K.; Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv  2015,22(8),1027-1042","journal-title":"Drug Deliv"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1567201816666190201143457","volume":"16","author":"Benson H.A.E.","year":"2019","unstructured":"Benson H.A.E.; Grice J.E.; Mohammed Y.; Namjoshi S.; Roberts M.S.; Topical and transdermal drug delivery: From simple potions to smart technologies. Curr Drug Deliv  2019,16(5),444-460","journal-title":"Curr Drug Deliv"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40005-018-00418-8","volume":"49","author":"Zeb A.","year":"2019","unstructured":"Zeb A.; Arif S.T.; Malik M.; Potential of nanoparticulate carriers for improved drug delivery via skin. J Pharm Investig  2019,49(5),485-517","journal-title":"J Pharm Investig"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/2229-5178.120635","volume":"4","author":"Gupta S.","year":"2013","unstructured":"Gupta S.; Bansal R.; Gupta S.; Jindal N.; Jindal A.; Nanocarriers and nanoparticles for skin care and dermatological treatments. Indian Dermatol Online J  2013,4(4),267-272","journal-title":"Indian Dermatol Online J"},{"key":"ref=25","first-page":"156","volume":"4","author":"Chiranjeevi C.","year":"2013","unstructured":"Chiranjeevi C.; Muthukumaran M.; Krishnamoorthy B.; A review on potency of vesicular systems in targeting drug delivery. RJPBCS  2013,4,156-170","journal-title":"RJPBCS"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1517\/17425240903071029","volume":"6","author":"Sinico C.","year":"2009","unstructured":"Sinico C.; Fadda A.M.; Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv  2009,6(8),813-825","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00403-011-1166-4","volume":"303","author":"Pierre M.B.R.","year":"2011","unstructured":"Pierre M.B.R.; dos Santos M.C.I.; Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res  2011,303(9),607-621","journal-title":"Arch Dermatol Res"},{"key":"ref=28","first-page":"24","volume":"1","author":"Dhamecha D.L.","year":"2009","unstructured":"Dhamecha D.L.; Rathi A.A.; Saifee M.; Lahoti S.; Dehghan M.; Drug vehicle based approaches of penetration enhancement. Int J Pharma Sci  2009,1(1),24-46","journal-title":"Int J Pharma Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"565285","DOI":"10.3389\/fimmu.2020.565285","volume":"11","author":"Lee Y.S.","year":"2020","unstructured":"Lee Y.S.; Jeon S.H.; Ham H.J.; Lee H.P.; Song M.J.; Hong J.T.; Improved anti-inflammatory effects of liposomal astaxanthin on a phthalic anhydride-induced atopic dermatitis model. Front Immunol  2020,11,565285","journal-title":"Front Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"122045","DOI":"10.1016\/j.ijpharm.2022.122045","volume":"624","author":"Javia A.","year":"2022","unstructured":"Javia A.; Misra A.; Thakkar H.; Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model. Int J Pharm  2022,624,122045","journal-title":"Int J Pharm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2005.11.045","volume":"311","author":"Manconi M.","year":"2006","unstructured":"Manconi M.; Sinico C.; Valenti D.; Lai F.; Fadda A.M.; Niosomes as carriers for tretinoin. Int J Pharm  2006,311(1-2),11-19","journal-title":"Int J Pharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"Kuotsu K.","year":"2010","unstructured":"Kuotsu K.; Karim K.M.; Mandal A.S.; Biswas N.; Guha A.; Chatterjee S.; Behera M.; Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res  2010,1(4),374-380","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08982104.2019.1614952","volume":"30","author":"Wichayapreechar P.","year":"2020","unstructured":"Wichayapreechar P.; Anuchapreeda S.; Phongpradist R.; Rungseevijitprapa W.; Ampasavate C.; Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes. J Liposome Res  2020,30(2),197-207","journal-title":"J Liposome Res"},{"key":"ref=34a","doi-asserted-by":"publisher","first-page":"122143","DOI":"10.1016\/j.ijpharm.2022.122143","volume":"626","author":"Bhardwaj P.","year":"2022","unstructured":"Bhardwaj P.; Tripathi P.; Pandey S.; Gupta R.; Ramchandra Patil P.; Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study. Int J Pharm  2022,626,122143","journal-title":"Int J Pharm"},{"key":"ref=34b","first-page":"305","volume":"14","author":"Touitou E.","year":"1997","unstructured":"Touitou E.; Alkabes M.; Dayan N.; Eliaz M.; Ethosomes: the novel vesicular carriers for enhanced skin delivery. Pharm Res  1997,14,305-306","journal-title":"Pharm Res"},{"key":"ref=35","first-page":"45","volume":"12","author":"Garg U.","year":"2022","unstructured":"Garg U.; Jain K.; Dermal and transdermal drug delivery through vesicles and particles: Preparation and applications. Adv Pharm Bull  2022,12(1),45-57","journal-title":"Adv Pharm Bull"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12906-019-2675-5","volume":"19","author":"Negi P.","year":"2019","unstructured":"Negi P.; Sharma I.; Hemrajani C.; Rathore C.; Bisht A.; Raza K.; Katare O.P.; Thymoquinone-loaded lipid vesicles: A promising nanomedicine for psoriasis. BMC Complement Altern Med  2019,19(1),334","journal-title":"BMC Complement Altern Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/2211738509666210208225826","volume":"9","author":"Kumar B.","year":"2021","unstructured":"Kumar B.; Sahoo P.K.; Manchanda S.; Curcumin loaded ethosomal gel for improved topical delivery: Formulation, characterization and ex-vivo studies. Pharm Nanotechnol  2021,9(4),281-287","journal-title":"Pharm Nanotechnol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1111\/jocd.13234","volume":"19","author":"Sasindran S.","year":"2020","unstructured":"Sasindran S.; Easwaran M.; Shyamala G.; Karuppaiah A.; Siram K.; Veintramuthu S.; Phytochemical screening and cytotoxicity evaluation of crude extracts: Toxicity comparison of crude extracts and its ethosomal formulations. J Cosmet Dermatol  2020,19(7),1794-1803","journal-title":"J Cosmet Dermatol"},{"key":"ref=39","author":"Cevc G.","year":"2008","unstructured":"Cevc G.; Richardsen H.; Weiland-Waibel A.;  Method for the improvement of transport across adaptable semi-permeable barriers  2008","journal-title":"Method for the improvement of transport across adaptable semi-permeable barriers"},{"key":"ref=40","first-page":"12","volume":"1","author":"Bhardwaj V.","year":"2010","unstructured":"Bhardwaj V.; Shukla V.; Singh A.; Malviya R.; Sharma P.; Transfersomes ultra flexible vesicles for transdermal delivery. IJPSR  2010,1(3),12-20","journal-title":"IJPSR"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/pharmaceutics14081695","volume":"14","author":"Uwaezuoke O.","year":"2022","unstructured":"Uwaezuoke O.; Du Toit L.C.; Kumar P.; Ally N.; Choonara Y.E.; Linoleic acid-based transferosomes for topical ocular delivery of cyclosporine A. Pharmaceutics  2022,14(8),1695","journal-title":"Pharmaceutics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"120990","DOI":"10.1016\/j.ijpharm.2021.120990","volume":"607","author":"Maji R.","year":"2021","unstructured":"Maji R.; Omolo C.A.; Jaglal Y.; Singh S.; Devnarain N.; Mocktar C.; Govender T.; A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride. Int J Pharm  2021,607,120990","journal-title":"Int J Pharm"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1248\/bpb.30.350","volume":"30","author":"Garg G.","year":"2007","unstructured":"Garg G.; Saraf S.; Saraf S.; Cubosomes: An overview. Biol Pharm Bull  2007,30(2),350-353","journal-title":"Biol Pharm Bull"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1039\/D2TB00031H","volume":"10","author":"Abourehab M.A.S.","year":"2022","unstructured":"Abourehab M.A.S.; Ansari M.J.; Singh A.; Hassan A.; Abdelgawad M.A.; Shrivastav P.; Abualsoud B.M.; Amaral L.S.; Pramanik S.; Cubosomes as an emerging platform for drug delivery: A review of the state of the art. J Mater Chem B Mater Biol Med  2022,10(15),2781-2819","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/IJN.S345430","volume":"17","author":"Shalaby R.A.","year":"2022","unstructured":"Shalaby R.A.; El-Gazayerly O.; Abdallah M.; Cubosomal betamethasone-salicylic acid nano drug delivery system for enhanced management of scalp psoriasis. Int J Nanomed  2022,17,1659-1677","journal-title":"Int J Nanomed"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3390\/molecules25204781","volume":"25","author":"Duong V.A.","year":"2020","unstructured":"Duong V.A.; Nguyen T.T.L.; Maeng H.J.; Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules  2020,25(20),4781","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N.; Valizadeh H.; Zakeri-Milani P.; Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull  2015,5(3),305-313","journal-title":"Adv Pharm Bull"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"112130","DOI":"10.1016\/j.biopha.2021.112130","volume":"143","author":"El-Telbany D.F.A.","year":"2021","unstructured":"El-Telbany D.F.A.; El-Telbany R.F.A.; Zakaria S.; Ahmed K.A.; El-Feky Y.A.; Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery. Biomed Pharmacother  2021,143,112130","journal-title":"Biomed Pharmacother"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"Khosa A.","year":"2018","unstructured":"Khosa A.; Reddi S.; Saha R.N.; Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother  2018,103,598-613","journal-title":"Biomed Pharmacother"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","volume":"394","author":"Zhuang C.Y.","year":"2010","unstructured":"Zhuang C.Y.; Li N.; Wang M.; Zhang X.N.; Pan W.S.; Peng J.J.; Pan Y.S.; Tang X.; Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm  2010,394(1-2),179-185","journal-title":"Int J Pharm"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"112658","DOI":"10.1016\/j.colsurfb.2022.112658","volume":"217","author":"Javia A.","year":"2022","unstructured":"Javia A.; Misra A.; Thakkar H.; Design and pharmacodynamic evaluation of DPK-060 loaded Nanostructured lipid carrier embedded gel for dermal delivery: A novel approach in the treatment of atopic dermatitis. Colloids Surf B Biointerfaces  2022,217,112658","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/2230-973X.104397","volume":"2","author":"Sabale V.","year":"2012","unstructured":"Sabale V.; Vora S.; Formulation and evaluation of microemulsion-based hydrogel for topical delivery. Int J Pharm Investig  2012,2(3),140-149","journal-title":"Int J Pharm Investig"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","volume":"45","author":"Lawrence M.J.","year":"2000","unstructured":"Lawrence M.J.; Rees G.D.; Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev  2000,45(1),89-121","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"110886","DOI":"10.1016\/j.colsurfb.2020.110886","volume":"189","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Cao Y.; Meng X.; Li C.; Wang H.; Zhang S.; Enhancement of transdermal delivery of artemisinin using microemulsion vehicle based on ionic liquid and lidocaine ibuprofen. Colloids Surf B Biointerfaces  2020,189,110886","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"111103","DOI":"10.1016\/j.colsurfb.2020.111103","volume":"193","author":"Subongkot T.","year":"2020","unstructured":"Subongkot T.; Sirirak T.; Development and skin penetration pathway evaluation of microemulsions for enhancing the dermal delivery of celecoxib. Colloids Surf B Biointerfaces  2020,193,111103","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","volume":"5","author":"Jaiswal M","year":"2015","unstructured":"Jaiswal M; Dudhe R; Sharma PK; Nanoemulsion: An advanced mode of drug delivery system. 3 Biotech  2015,5(2),123-127","journal-title":"3 Biotech"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2174\/1567201819666220819110128","volume":"20","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Yao Y.; Liu H.; Ma Q.; Huang L.; Chen Y.; Lin H.; Desonide nanoemulsion gel for transdermal absorption drug delivery: Pharmacodynamic and safety evaluation. Curr Drug Deliv  2022,20(10),1525-1532","journal-title":"Curr Drug Deliv"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"118979","DOI":"10.1016\/j.ijpharm.2019.118979","volume":"576","author":"Juri\u0161i\u0107 Dukovski B.","year":"2020","unstructured":"Juri\u0161i\u0107 Dukovski B.; Jureti\u0107 M.; Bra\u010dko D.; Randjelovi\u0107 D.; Savi\u0107 S.; Crespo M.M.; Diebold Y.; Filipovi\u0107-Gr\u010di\u0107 J.; Pepi\u0107 I.; Lovri\u0107 J.; Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment. Int J Pharm  2020,576,118979","journal-title":"Int J Pharm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11095-015-1784-1","volume":"33","author":"Gothwal A.","year":"2016","unstructured":"Gothwal A.; Khan I.; Gupta U.; Polymeric micelles: Recent advancements in the delivery of anticancer drugs. Pharm Res  2016,33(1),18-39","journal-title":"Pharm Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/polym13030477","volume":"13","author":"Atanase L.I.","year":"2021","unstructured":"Atanase L.I.; Micellar drug delivery systems based on natural biopolymers. Polymers  2021,13(3),477","journal-title":"Polymers"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1080\/03639045.2022.2077957","volume":"47","author":"Shen C.","year":"2021","unstructured":"Shen C.; Shen B.; Zhu J.; Yuan H.; Hu J.; Topical delivery of pluronic F127\/TPGS mixed micelles-based hydrogel loaded with glycyrrhizic acid for atopic dermatitis treatment. Drug Dev Ind Pharm  2021,47(12),1975-1985","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=62a","doi-asserted-by":"publisher","first-page":"121916","DOI":"10.1016\/j.ijpharm.2022.121916","volume":"623","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Tang Z.; Guo X.; Zhao Y.; Ren S.; Zhang Z.; Lv H.; Hyaluronic acid-cyclodextrin encapsulating paeonol for treatment of atopic dermatitis. Int J Pharm  2022,623,121916","journal-title":"Int J Pharm"},{"key":"ref=62b","first-page":"155","volume":"2","author":"Vogtle F.","year":"1997","unstructured":"Vogtle F.; Buhleier E.W.; Wehner W.; Cascade and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis  1997,2,155-158","journal-title":"Synthesis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.3390\/molecules25194489","volume":"25","author":"Maysinger D.","year":"2020","unstructured":"Maysinger D.; Zhang Q.; Kakkar A.; Dendrimers as modulators of brain cells. Molecules  2020,25(19),4489","journal-title":"Molecules"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijpharm.2018.07.030","volume":"548","author":"Sherje A.P.","year":"2018","unstructured":"Sherje A.P.; Jadhav M.; Dravyakar B.R.; Kadam D.; Dendrimers: A versatile nanocarrier for drug delivery and targeting. Int J Pharm  2018,548(1),707-720","journal-title":"Int J Pharm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s13346-021-00933-6","volume":"11","author":"G\u00f6k\u00e7e B.B.","year":"2021","unstructured":"G\u00f6k\u00e7e B.B.; Boran T.; Emlik \u00c7al\u0131k F.; \u00d6zhan G.; Sanyal R.; G\u00fcng\u00f6r S.; Dermal delivery and follicular targeting of adapalene using PAMAM dendrimers. Drug Deliv Transl Res  2021,11(2),626-646","journal-title":"Drug Deliv Transl Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1606134","DOI":"10.1002\/adma.201606134","volume":"29","author":"Wu M.X.","year":"2017","unstructured":"Wu M.X.; Yang Y.W.; Metal\u2013organic framework (MOF)\u2010based drug\/cargo delivery and cancer therapy. Adv Mater  2017,29(23),1606134","journal-title":"Adv Mater"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2174\/0929867325666180214123500","volume":"26","author":"Luo Z.","year":"2019","unstructured":"Luo Z.; Fan S.; Gu C.; Liu W.; Chen J.; Li B.; Liu J.; Metal\u2013organic framework (MOF)-based nanomaterials for biomedical applications. Curr Med Chem  2019,26(18),3341-3369","journal-title":"Curr Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1021\/cr200256v","volume":"112","author":"Horcajada P.","year":"2012","unstructured":"Horcajada P.; Gref R.; Baati T.; Allan P.K.; Maurin G.; Couvreur P.; F\u00e9rey G.; Morris R.E.; Serre C.; Metal-organic frameworks in biomedicine. Chem Rev  2012,112(2),1232-1268","journal-title":"Chem Rev"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/cmdc.201900546","volume":"15","author":"Li Z.","year":"2020","unstructured":"Li Z.; Peng Y.; Pang X.; Tang B.; Potential therapeutic effects of Mg\/HCOOH metal organic framework on relieving osteoarthritis. ChemMedChem  2020,15(1),13-16","journal-title":"ChemMedChem"},{"key":"ref=70","first-page":"13","volume":"1","author":"Sipai A","year":"2012","unstructured":"Sipai A; Vandana Y; Mamatha Y; Prasanth, VJJPSI Liposomes: An overview.  2012,1(1),13-21"},{"key":"ref=71","first-page":"27","volume":"51","author":"Bhaskaran S.","year":"2009","unstructured":"Bhaskaran S.; Lakshmi P.; Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharmaceut Sci  2009,51(1),27-32","journal-title":"Acta Pharmaceut Sci"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.79807","author":"Sankar V.","year":"2018","unstructured":"Sankar V.; Ramesh S.; Siram K.; Ethosomes: An exciting and promising alcoholic carrier system for treating androgenic alopecia. Alopecia  2018","journal-title":"Alopecia"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/15672018113106660064","volume":"11","author":"Akhtar N.","year":"2014","unstructured":"Akhtar N.; Vesicles: A recently developed novel carrier for enhanced topical drug delivery. Curr Drug Deliv  2014,11(1),87-97","journal-title":"Curr Drug Deliv"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"Bozzuto G.","year":"2015","unstructured":"Bozzuto G.; Molinari A.; Liposomes as nanomedical devices. Int J Nanomed  2015,10,975-999","journal-title":"Int J Nanomed"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics8040036","volume":"8","author":"Ong S.","year":"2016","unstructured":"Ong S.; Chitneni M.; Lee K.; Ming L.; Yuen K.; Evaluation of extrusion technique for nanosizing liposomes. Pharmaceutics  2016,8(4),36","journal-title":"Pharmaceutics"},{"key":"ref=76","first-page":"211","author":"Cannon J.B.","year":"2018","unstructured":"Cannon J.B.; Shi Y.; Gupta P.; Emulsions, microemulsions, and lipid-based drug delivery systems for drug solubilization and delivery\u2014Part I: Parenteral applications. Water-insoluble drug formulation  2018,211-245","journal-title":"Water-insoluble drug formulation"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"Lombardo D.","year":"2022","unstructured":"Lombardo D.; Kiselev M.A.; Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics  2022,14(3),543","journal-title":"Pharmaceutics"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A.; Rezaei-Sadabady R.; Davaran S.; Joo S.W.; Zarghami N.; Hanifehpour Y.; Samiei M.; Kouhi M.; Nejati-Koshki K.; Liposome: Classification, preparation, and applications. Nanoscale Res Lett  2013,8(1),102","journal-title":"Nanoscale Res Lett"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.9734\/jpri\/2020\/v32i630449","author":"Hasan M.M.","year":"2020","unstructured":"Hasan M.M.; Hamiduzzaman M.; Jahan I.; Hasan A.N.; Zaman M.A.; Formulation development, characterization and in vitro evaluation of tamoxifen loaded liposomes. Int J Pharm Res  2020(May),64-82","journal-title":"Int J Pharm Res"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.33786\/JCPR.2014.v04i02.010","volume":"4","author":"Patil R.","year":"2014","unstructured":"Patil R.; Patil S.; Patil S.; Patil S.; Patil S.; Ethosome: A versatile tool for novel drug delivery system. J Curr Pharma Res  2014,4(2),1172","journal-title":"J Curr Pharma Res"},{"key":"ref=81","first-page":"72","volume":"66","author":"Jain S.","year":"2004","unstructured":"Jain S.; Umamaheshwari R.; Bhadra D.; Jain N.; Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an antiHIV agent. Indian J Pharm Sci  2004,66(1),72","journal-title":"Indian J Pharm Sci"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1567201813666160520114436","volume":"14","author":"Garg V.","year":"2017","unstructured":"Garg V.; Singh H.; Bimbrawh S.; Singh S.K.; Gulati M.; Vaidya Y.; Kaur P.; Ethosomes and transfersomes: Principles, perspectives and practices. Curr Drug Deliv  2017,14(5),613-633","journal-title":"Curr Drug Deliv"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/ma13010065","volume":"13","author":"Santos A.","year":"2019","unstructured":"Santos A.; Veiga F.; Figueiras A.; Dendrimers as pharmaceutical excipients: Synthesis, properties, toxicity and biomedical applications. Materials  2019,13(1),65","journal-title":"Materials"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1039\/D0TB00942C","volume":"8","author":"Saviano F.","year":"2020","unstructured":"Saviano F.; Lovato T.; Russo A.; Russo G.; Bouton C.R.; Shattock R.J.; Alexander C.; Quaglia F.; Blakney A.K.; Gurnani P.; Conte C.; Ornithine-derived oligomers and dendrimers for in vitro delivery of DNA and ex vivo transfection of skin cells via saRNA. J Mater Chem B Mater Biol Med  2020,8(22),4940-4949","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0975-7406.130965","volume":"6","author":"Pandita D.","year":"2014","unstructured":"Pandita D.; Madaan K.; Kumar S.; Poonia N.; Lather V.; Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci  2014,6(3),139-150","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"31553","DOI":"10.1039\/D0RA05289B","volume":"10","author":"Agrahari A.K.","year":"2020","unstructured":"Agrahari A.K.; Singh A.S.; Mukherjee R.; Tiwari V.K.; An expeditious click approach towards the synthesis of galactose coated novel glyco-dendrimers and dentromers utilizing a double stage convergent method. RSC Advances  2020,10(52),31553-31562","journal-title":"RSC Advances"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ejpb.2017.07.015","volume":"119","author":"Esposito E.","year":"2017","unstructured":"Esposito E.; Sguizzato M.; Drechsler M.; Mariani P.; Carducci F.; Nastruzzi C.; Cortesi R.; Progesterone lipid nanoparticles: Scaling up and in vivo human study. Eur J Pharm Biopharm  2017,119,437-446","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"Mehnert W.","year":"2001","unstructured":"Mehnert W.; M\u00e4der K.; Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev  2001,47(2-3),165-196","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejpb.2016.06.014","volume":"108","author":"Suter F.","year":"2016","unstructured":"Suter F.; Schmid D.; Wandrey F.; Z\u00fclli F.; Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications. Eur J Pharm Biopharm  2016,108,304-309","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2008.02.007","volume":"128","author":"Anton N.","year":"2008","unstructured":"Anton N.; Benoit J.P.; Saulnier P.; Design and production of nanoparticles formulated from nano-emulsion templates\u2014A review. J Control Release  2008,128(3),185-199","journal-title":"J Control Release"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-01095-1","author":"Akanda M.","year":"2021","unstructured":"Akanda M.; Getti G.; Douroumis D.; In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours. Drug Deliv Transl Res  2021","journal-title":"Drug Deliv Transl Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/10837450.2019.1647235","volume":"24","author":"Souto E.B.","year":"2019","unstructured":"Souto E.B.; Doktorovova S.; Zielinska A.; Silva A.M.; Key production parameters for the development of solid lipid nanoparticles by high shear homogenization. Pharm Dev Technol  2019,24(9),1181-1185","journal-title":"Pharm Dev Technol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.colsurfb.2010.12.014","volume":"83","author":"Xie S.","year":"2011","unstructured":"Xie S.; Zhu L.; Dong Z.; Wang X.; Wang Y.; Li X.; Zhou W.; Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: Influences of fatty acids. Colloids Surf B Biointerfaces  2011,83(2),382-387","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.colsurfb.2015.04.055","volume":"131","author":"Sangsen Y.","year":"2015","unstructured":"Sangsen Y.; Wiwattanawongsa K.; Likhitwitayawuid K.; Sritularak B.; Wiwattanapatapee R.; Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Colloids Surf B Biointerfaces  2015,131,182-190","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-4939-9516-5_19","volume":"2000","author":"Joshi M.D.","year":"2019","unstructured":"Joshi M.D.; Prabhu R.H.; Patravale V.B.; Fabrication of nanostructured lipid carriers (NLC)-based gels from microemulsion template for delivery through skin. Methods Mol Biol  2019,2000,279-292","journal-title":"Methods Mol Biol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-5173(03)00135-2","volume":"257","author":"Trotta M.","year":"2003","unstructured":"Trotta M.; Debernardi F.; Caputo O.; Preparation of solid lipid nanoparticles by a solvent emulsification\u2013diffusion technique. Int J Pharm  2003,257(1-2),153-160","journal-title":"Int J Pharm"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/adt.2020.1029","volume":"19","author":"Puri D.","year":"2021","unstructured":"Puri D.; Mishra A.; Singh A.P.; Gaur P.K.; Singh M.; Yasir M.; Formulation development of topical preparation containing nanoparticles of povidone-iodine for wound healing. Assay Drug Dev Technol  2021,19(2),115-123","journal-title":"Assay Drug Dev Technol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.chemphyslip.2015.09.008","volume":"193","author":"Pooja D.","year":"2015","unstructured":"Pooja D.; Tunki L.; Kulhari H.; Reddy B.B.; Sistla R.; Characterization, biorecognitive activity and stability of WGA grafted lipid nanostructures for the controlled delivery of Rifampicin. Chem Phys Lipids  2015,193,11-17","journal-title":"Chem Phys Lipids"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","volume":"56","author":"Wissing S.A.","year":"2004","unstructured":"Wissing S.A.; Kayser O.; M\u00fcller R.H.; Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev  2004,56(9),1257-1272","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2217\/nnm-2020-0003","volume":"15","author":"SS Pindiprolu S.K.","year":"2020","unstructured":"SS Pindiprolu S.K.; Krishnamurthy P.T.; Ghanta V.R.; Chintamaneni P.K.; Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer. Nanomedicine  2020,15(16),1551-1565","journal-title":"Nanomedicine"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.colsurfb.2018.12.048","volume":"176","author":"Mazur K.L.","year":"2019","unstructured":"Mazur K.L.; Feuser P.E.; Val\u00e9rio A.; Poester Cordeiro A.; de Oliveira C.I.; Assolini J.P.; Pavanelli W.R.; Sayer C.; Ara\u00fajo P.H.H.; Diethyldithiocarbamate loaded in beeswax-copaiba oil nanoparticles obtained by solventless double emulsion technique promote promastigote death in vitro. Colloids Surf B Biointerfaces  2019,176,507-512","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/02652040802390156","volume":"26","author":"Gallarate M.","year":"2009","unstructured":"Gallarate M.; Trotta M.; Battaglia L.; Chirio D.; Preparation of solid lipid nanoparticles from W\/O\/W emulsions: Preliminary studies on insulin encapsulation. J Microencapsul  2009,26(5),394-402","journal-title":"J Microencapsul"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/nano12173054","volume":"12","author":"Subroto E.","year":"2022","unstructured":"Subroto E.; Andoyo R.; Indiarto R.; Wulandari E.; Wadhiah E.F.N.; Preparation of solid lipid nanoparticle-ferrous sulfate by double emulsion method based on fat rich in monolaurin and stearic acid. Nanomaterial  2022,12(17),3054","journal-title":"Nanomaterial"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/02726351.2017.1295293","volume":"36","author":"Ali H.","year":"2018","unstructured":"Ali H.; Singh S.K.; Preparation and characterization of solid lipid nanoparticles of furosemide using quality by design. Particul Sci Technol  2018,36(6),695-709","journal-title":"Particul Sci Technol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/fsn3.1422","volume":"8","author":"Vinh T.D.T.","year":"2020","unstructured":"Vinh T.D.T.; Hien L.T.M.; Dao D.T.A.; Formulation of black pepper (Piper nigrum L.) essential oil nano\u2010emulsion via phase inversion temperature method. Food Sci Nutr  2020,8(4),1741-1752","journal-title":"Food Sci Nutr"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/nnm-2016-0380","volume":"12","author":"Battaglia L.","year":"2017","unstructured":"Battaglia L.; Muntoni E.; Chirio D.; Peira E.; Annovazzi L.; Schiffer D.; Mellai M.; Riganti C.; Salaroglio I.C.; Lanotte M.; Panciani P.; Capucchio M.T.; Valazza A.; Biasibetti E.; Gallarate M.; Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment. Nanomedicine  2017,12(6),639-656","journal-title":"Nanomedicine"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"255102","DOI":"10.1088\/0957-4484\/26\/25\/255102","volume":"26","author":"Battaglia L.","year":"2015","unstructured":"Battaglia L.; Gallarate M.; Peira E.; Chirio D.; Solazzi I.; Giordano S.M.A.; Gigliotti C.L.; Riganti C.; Dianzani C.; Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: Preliminary in vitro studies. Nanotechnology  2015,26(25),255102","journal-title":"Nanotechnology"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00592-019-01403-9","volume":"56","author":"Muntoni E.","year":"2019","unstructured":"Muntoni E.; Marini E.; Ahmadi N.; Milla P.; Gh\u00e8 C.; Bargoni A.; Capucchio M.T.; Biasibetti E.; Battaglia L.; Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: Preliminary ex vivo and in vivo studies. Acta Diabetol  2019,56(12),1283-1292","journal-title":"Acta Diabetol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/anie.201804067","volume":"58","author":"Barriga H.M.G.","year":"2019","unstructured":"Barriga H.M.G.; Holme M.N.; Stevens M.M.; Cubosomes: The next generation of smart lipid nanoparticles? Angew Chem Int Ed  2019,58(10),2958-2978","journal-title":"Angew Chem Int Ed"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/pharmaceutics14030600","volume":"14","author":"Almoshari Y.","year":"2022","unstructured":"Almoshari Y.; Development, therapeutic evaluation and theranostic applications of cubosomes on cancers: An updated review. Pharmaceutics  2022,14(3),600","journal-title":"Pharmaceutics"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11095-020-02857-1","volume":"37","author":"Gaballa S.A.","year":"2020","unstructured":"Gaballa S.A.; El Garhy O.H.; Moharram H.; Abdelkader H.; Preparation and evaluation of cubosomes\/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res  2020,37(10),198","journal-title":"Pharm Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcis.2021.05.072","volume":"601","author":"Bryant S.J.","year":"2021","unstructured":"Bryant S.J.; Bathke E.K.; Edler K.J.; Bottom-up cubosome synthesis without organic solvents. J Colloid Interface Sci  2021,601,98-105","journal-title":"J Colloid Interface Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","volume":"117","author":"Gill H.S.","year":"2007","unstructured":"Gill H.S.; Prausnitz M.R.; Coated microneedles for transdermal delivery. J Control Release  2007,117(2),227-237","journal-title":"J Control Release"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40005-021-00512-4","volume":"51","author":"Jung J.H.","year":"2021","unstructured":"Jung J.H.; Jin S.G.; Microneedle for transdermal drug delivery: Current trends and fabrication. J Pharm Investig  2021,51(5),503-517","journal-title":"J Pharm Investig"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1364\/OE.18.017967","volume":"18","author":"Omatsu T.","year":"2010","unstructured":"Omatsu T.; Chujo K.; Miyamoto K.; Okida M.; Nakamura K.; Aoki N.; Morita R.; Metal microneedle fabrication using twisted light with spin. Opt Express  2010,18(17),17967-17973","journal-title":"Opt Express"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2014.04.052","volume":"185","author":"Indermun S.","year":"2014","unstructured":"Indermun S.; Luttge R.; Choonara Y.E.; Kumar P.; du Toit L.C.; Modi G.; Pillay V.; Current advances in the fabrication of microneedles for transdermal delivery. J Control Release  2014,185,130-138","journal-title":"J Control Release"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/03639045.2018.1539497","volume":"45","author":"Dharadhar S.","year":"2019","unstructured":"Dharadhar S.; Majumdar A.; Dhoble S.; Patravale V.; Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm  2019,45(2),188-201","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.3390\/s131216672","volume":"13","author":"Yoon Y.","year":"2013","unstructured":"Yoon Y.; Lee G.; Yoo K.; Lee J.B.; Fabrication of a microneedle\/CNT hierarchical micro\/nano surface electrochemical sensor and its in-vitro glucose sensing characterization. Sensors (Basel)  2013,13(12),16672-16681","journal-title":"Sensors (Basel)"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.3390\/ma8125484","volume":"8","author":"Dardano P.","year":"2015","unstructured":"Dardano P.; Cali\u00f2 A.; Di Palma V.; Bevilacqua M.; Di Matteo A.; De Stefano L.; A photolithographic approach to polymeric microneedles array fabrication. Materials (Basel)  2015,8(12),8661-8673","journal-title":"Materials (Basel)"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jconrel.2013.05.026","volume":"170","author":"Kim J.D.","year":"2013","unstructured":"Kim J.D.; Kim M.; Yang H.; Lee K.; Jung H.; Droplet-born air blowing: Novel dissolving microneedle fabrication. J Control Release  2013,170(3),430-436","journal-title":"J Control Release"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41378-021-00298-3","volume":"7","author":"Faraji Rad Z.","year":"2021","unstructured":"Faraji Rad Z.; Prewett P.D.; Davies G.J.; High-resolution two-photon polymerization: the most versatile technique for the fabrication of microneedle arrays. Microsyst Nanoeng  2021,7(1),71","journal-title":"Microsyst Nanoeng"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jconrel.2019.11.023","volume":"317","author":"Balmert S.C.","year":"2020","unstructured":"Balmert S.C.; Carey C.D.; Falo G.D.; Sethi S.K.; Erdos G.; Korkmaz E.; Falo L.D.; Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination. J Control Release  2020,317,336-346","journal-title":"J Control Release"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"231","DOI":"10.22270\/jddt.v3i4.590","volume":"3","author":"Prabhakar D.","year":"2013","unstructured":"Prabhakar D.; Sreekanth J.; Jayaveera K.N.; Transdermal drug delivery patches: A review. J Drug Deliv Ther  2013,3(4),231-21","journal-title":"J Drug Deliv Ther"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-12-814487-9.00004-1","author":"Keservani R.K.","year":"2020","unstructured":"Keservani R.K.; Bandopadhyay S.; Bandyopadhyay N.; Sharma A.K.; Design and fabrication of transdermal\/skin drug-delivery system. Drug Delivery Systems  2020,131-178","journal-title":"Drug Delivery Systems"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-12-802926-8.00013-6","author":"Abdel-Mottaleb M.","year":"2016","unstructured":"Abdel-Mottaleb M.; Nanoparticles for treatment of atopic dermatitis. Nanoscience in Dermatology  2016,167-175","journal-title":"Nanoscience in Dermatology"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/pharmaceutics11050231","volume":"11","author":"Carbone C.","year":"2019","unstructured":"Carbone C.; Teixeira M.C.; Sousa M.C.; Martins-Gomes C.; Silva A.M.; Souto E.M.B.; Musumeci T.; Clotrimazole-loaded mediterranean essential oils nlc: a synergic treatment of Candida skin infections. Pharmaceutics  2019,11(5),231","journal-title":"Pharmaceutics"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/978-981-15-0263-7_15","author":"Yilmaz A.H.","year":"2019","unstructured":"Yilmaz A.H.; Antibacterial activity of chitosan-based systems. Functional chitosan  2019,457-489","journal-title":"Functional chitosan"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbrc.2013.08.001","volume":"439","author":"Ye R.","year":"2013","unstructured":"Ye R.; Xu H.; Wan C.; Peng S.; Wang L.; Xu H.; Aguilar Z.P.; Xiong Y.; Zeng Z.; Wei H.; Antibacterial activity and mechanism of action of \u03b5-poly-l-lysine. Biochem Biophys Res Commun  2013,439(1),148-153","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jconrel.2021.07.002","volume":"336","author":"Kotla N.G.","year":"2021","unstructured":"Kotla N.G.; Bonam S.R.; Rasala S.; Wankar J.; Bohara R.A.; Bayry J.; Rochev Y.; Pandit A.; Recent advances and prospects of hyaluronan as a multifunctional therapeutic system. J Control Release  2021,336,598-620","journal-title":"J Control Release"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/08982104.2016.1254241","volume":"28","author":"Akhtar N.","year":"2018","unstructured":"Akhtar N.; Verma A.; Pathak K.; Investigating the penetrating potential of nanocomposite \u03b2-cycloethosomes: Development using central composite design, in vitro and ex vivo characterization. J Liposome Res  2018,28(1),35-48","journal-title":"J Liposome Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1208\/s12249-019-1355-6","volume":"20","author":"Assem M.","year":"2019","unstructured":"Assem M.; Khowessah O.M.; Ghorab D.; Optimization and evaluation of beclomethasone dipropionate micelles incorporated into biocompatible hydrogel using a sub-chronic dermatitis animal model. AAPS Pharm Sci Tech  2019,20(4),152","journal-title":"AAPS Pharm Sci Tech"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.09.002","volume":"383","author":"Baspinar Y.","year":"2010","unstructured":"Baspinar Y.; Keck C.M.; Borchert H.H.; Development of a positively charged prednicarbate nanoemulsion. Int J Pharm  2010,383(1-2),201-208","journal-title":"Int J Pharm"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/08982104.2014.899365","volume":"24","author":"Goindi S.","year":"2014","unstructured":"Goindi S.; Kumar G.; Kaur A.; Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model. J Liposome Res  2014,24(3),249-257","journal-title":"J Liposome Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/pharmaceutics13030418","volume":"13","author":"Guillot A.J.","year":"2021","unstructured":"Guillot A.J.; Jornet-Moll\u00e1 E.; Landsberg N.; Mili\u00e1n-Guimer\u00e1 C.; Montesinos M.C.; Garrigues T.M.; Melero A.; Cyanocobalamin ultraflexible lipid vesicles: Characterization and in vitro evaluation of drug-skin depth profiles. Pharmaceutics  2021,13(3),418","journal-title":"Pharmaceutics"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1248\/bpb.b19-00259","volume":"42","author":"Ibaraki H.","year":"2019","unstructured":"Ibaraki H.; Kanazawa T.; Kurano T.; Oogi C.; Takashima Y.; Seta Y.; Anti-RelA siRNA-encapsulated flexible liposome with tight junction-opening peptide as a non-invasive topical therapeutic for atopic dermatitis. Biol Pharm Bull  2019,42(7),1216-1225","journal-title":"Biol Pharm Bull"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/pharmaceutics12030255","volume":"12","author":"Espinoza L.C.","year":"2020","unstructured":"Espinoza L.C.; Vera-Garc\u00eda R.; Silva-Abreu M.; Dom\u00e8nech \u00d2.; Badia J.; Rodr\u00edguez-Lagunas M.J.; Clares B.; Calpena A.C.; Topical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model. Pharmaceutics  2020,12(3),255","journal-title":"Pharmaceutics"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3109\/02652048.2014.932027","volume":"31","author":"Jahn A.","year":"2014","unstructured":"Jahn A.; Song C.K.; Balakrishnan P.; Hong S.S.; Lee J.H.; Chung S.J.; Kim D.D.; AAPE proliposomes for topical atopic dermatitis treatment. J Microencapsul  2014,31(8),768-773","journal-title":"J Microencapsul"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/08982104.2021.1880436","volume":"32","author":"Kumar P.","year":"2022","unstructured":"Kumar P.; Sharma D.K.; Ashawat M.S.; Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: Development, characterization, and in vivo investigation using BALB\/c mice model. J Liposome Res  2022,32(1),62-73","journal-title":"J Liposome Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3109\/03639045.2013.819883","volume":"40","author":"Kwon T.K.","year":"2014","unstructured":"Kwon T.K.; Kim J.C.; In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of Houttuynia cordata. Drug Dev Ind Pharm  2014,40(10),1350-1357","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=140","doi-asserted-by":"crossref","DOI":"10.3390\/nano12040636","volume":"12","author":"Saini K.","year":"2022","unstructured":"Saini K.; Modgill N.; Singh K.K.; Kakkar V.; Tetrahydrocurcumin lipid nanoparticle based gel promotes penetration into deeper skin layers and alleviates atopic dermatitis in 2,4-dinitrochlorobenzene (DNCB) mouse model. Nanomaterials  2022,12(4)","journal-title":"Nanomaterials"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s13346-019-00693-4","volume":"10","author":"Carreras J.J.","year":"2020","unstructured":"Carreras J.J.; Tapia-Ramirez W.E.; Sala A.; Guillot A.J.; Garrigues T.M.; Melero A.; Ultraflexible lipid vesicles allow topical absorption of cyclosporin A. Drug Deliv Transl Res  2020,10(2),486-497","journal-title":"Drug Deliv Transl Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ijbiomac.2017.07.087","volume":"105","author":"Muxika A.","year":"2017","unstructured":"Muxika A.; Etxabide A.; Uranga J.; Guerrero P.; de la Caba K.; Chitosan as a bioactive polymer: Processing, properties and applications. Int J Biol Macromol  2017,105(Pt 2),1358-1368","journal-title":"Int J Biol Macromol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/polym13071027","volume":"13","author":"De Leo V.","year":"2021","unstructured":"De Leo V.; Milano F.; Agostiano A.; Catucci L.; Recent advancements in polymer\/liposome assembly for drug delivery: From surface modifications to hybrid vesicles. Polymers  2021,13(7),1027","journal-title":"Polymers"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.jddst.2020.102046","volume":"60","author":"Kurakula M.","year":"2020","unstructured":"Kurakula M.; Rao G.S.N.K.; Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Deliv Sci Technol  2020,60,102046","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"22833","DOI":"10.3390\/molecules201219884","volume":"20","author":"Gaaz T.","year":"2015","unstructured":"Gaaz T.; Sulong A.; Akhtar M.; Kadhum A.; Mohamad A.; Al-Amiery A.; Properties and applications of polyvinyl alcohol, halloysite nanotubes and their nanocomposites. Molecules  2015,20(12),22833-22847","journal-title":"Molecules"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.conbuildmat.2015.12.188","volume":"107","author":"Thong C.C.","year":"2016","unstructured":"Thong C.C.; Teo D.C.L.; Ng C.K.; Application of polyvinyl alcohol (PVA) in cement-based composite materials: A review of its engineering properties and microstructure behavior. Constr Build Mater  2016,107,172-180","journal-title":"Constr Build Mater"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bpc.2013.02.004","volume":"175-176","author":"Mirti\u010d A.","year":"2013","unstructured":"Mirti\u010d A.; Grdadolnik J.; The structure of poly-l-lysine in different solvents. Biophys Chem  2013,175-176,47-53","journal-title":"Biophys Chem"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"e10261","DOI":"10.1002\/btm2.10261","volume":"7","author":"Zarrintaj P.","year":"2021","unstructured":"Zarrintaj P.; Ghorbani S.; Barani M.; Singh Chauhan N.P.; Khodadadi Y.M.; Saeb M.R.; Ramsey J.D.; Hamblin M.R.; Mozafari M.; Mostafavi E.; Polylysine for skin regeneration: A review of recent advances and future perspectives. Bioeng Transl Med  2021,7(1),e10261","journal-title":"Bioeng Transl Med"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10856-015-5493-4","volume":"26","author":"Diniz I.M.A.","year":"2015","unstructured":"Diniz I.M.A.; Chen C.; Xu X.; Ansari S.; Zadeh H.H.; Marques M.M.; Shi S.; Moshaverinia A.; Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells. J Mater Sci Mater Med  2015,26(3),153","journal-title":"J Mater Sci Mater Med"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/B978-0-12-814831-0.00033-6","author":"de Vries R.","year":"2020","unstructured":"de Vries R.; Stell A.; Mohammed S.; Bioengineering, biomaterials, and \u03b2-cell replacement therapy. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas  2020,461-486","journal-title":"Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.3390\/molecules26154429","volume":"26","author":"Juncan A.M.","year":"2021","unstructured":"Juncan A.M.; Mois\u0103 D.G.; Santini A.; Morgovan C.; Rus L.L.; Vonica-\u021aincu A.L.; Loghin F.; Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals. Molecules  2021,26(15),4429","journal-title":"Molecules"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/17425247.2013.736962","volume":"10","author":"Thakral S.","year":"2013","unstructured":"Thakral S.; Thakral N.K.; Majumdar D.K.; Eudragit\u00ae: A technology evaluation. Expert Opin Drug Deliv  2013,10(1),131-149","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1039\/c1py00034a","volume":"2","author":"Alconcel S.N.S.","year":"2011","unstructured":"Alconcel S.N.S.; Baas A.S.; Maynard H.D.; FDA-approved poly(ethylene glycol)\u2013protein conjugate drugs. Polym Chem  2011,2(7),1442-1448","journal-title":"Polym Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","volume":"37","author":"Lee K.Y.","year":"2012","unstructured":"Lee K.Y.; Mooney D.J.; Alginate: Properties and biomedical applications. Prog Polym Sci  2012,37(1),106-126","journal-title":"Prog Polym Sci"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-809261-3.00003-6","author":"Deshmukh K.","year":"2017","unstructured":"Deshmukh K.; Ahamed M.B.; Deshmukh R.; Pasha S.K.; Bhagat P.; Chidambaram K.; Biopolymer composites with high dielectric performance: interface engineering. Biopolymer composites in electronics  2017,27-128","journal-title":"Biopolymer composites in electronics"},{"key":"ref=156","author":"Manoukian O.S.","year":"2019","unstructured":"Manoukian O.S.; Sardashti N.; Stedman T.; Biomaterials for tissue engineering and regenerative medicine. J Funct Biomater  2019","journal-title":"J Funct Biomater"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"Makadia H.K.","year":"2011","unstructured":"Makadia H.K.; Siegel S.J.; Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers  2011,3(3),1377-1397","journal-title":"Polymers"},{"key":"ref=158","first-page":"317","author":"D\u00fcrig T.","year":"2019","unstructured":"D\u00fcrig T.; Karan K.; Binders in wet granulation. Handbook of pharmaceutical wet granulation  2019,317-349","journal-title":"Handbook of pharmaceutical wet granulation"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/B978-0-12-814487-9.00014-4","author":"Kapoor D.","year":"2020","unstructured":"Kapoor D.; Maheshwari R.; Verma K.; Sharma S.; Ghode P.; Tekade R.K.; Coating technologies in pharmaceutical product development. Drug Delivery Systems  2020,665-719","journal-title":"Drug Delivery Systems"},{"key":"ref=160","unstructured":"FDA. Highlights of prescribing information on EXPAREL (Bupivacaine Liposome Injectable Suspension)  Available from:  https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022496s000lbl.pdf"},{"key":"ref=161","unstructured":"Starpharma. VivaGel\u00ae Products Available from:  https:\/\/www.starpharma.com\/vivagel"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bfopcu.2017.10.001","volume":"55","author":"Jamkhande P.G.","year":"2017","unstructured":"Jamkhande P.G.; Ghante M.H.; Ajgunde B.R.; Software based approaches for drug designing and development: A systematic review on commonly used software and its applications. Bull Fac Pharm Cairo Univ  2017,55(2),203-210","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4236\/ojmc.2012.24017","volume":"2","author":"Kore P.P.","year":"2012","unstructured":"Kore P.P.; Mutha M.M.; Antre R.V.; Oswal R.J.; Kshirsagar S.S.; Computer-aided drug design: An innovative tool for modeling. Open J Med Chem  2012,2(4),139-148","journal-title":"Open J Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.2174\/1568026618666180101163651","volume":"17","author":"Usha T.","year":"2018","unstructured":"Usha T.; Shanmugarajan D.; Goyal A.K.; Kumar C.S.; Middha S.K.; Recent updates on computer-aided drug discovery: Time for a paradigm shift. Curr Top Med Chem  2018,17(30),3296-3307","journal-title":"Curr Top Med Chem"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"428378","DOI":"10.1155\/2013\/428378","volume":"2013","author":"Usha T.","year":"2013","unstructured":"Usha T.; Tripathi P.; Pande V.; Middha S.K.; Molecular docking and quantum mechanical studies on pelargonidin-3-glucoside as renoprotective ACE inhibitor. Int Sch Res Notices  2013,2013,428378","journal-title":"Int Sch Res Notices"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21533\/pen.v5i3.145","volume":"5","author":"Durakovic B.","year":"2017","unstructured":"Durakovic B.; Design of experiments application, concepts, examples: State of the art. Period Eng Nat Sci (PEN)  2017,5(3),421-439","journal-title":"Period Eng Nat Sci (PEN)"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.foodres.2013.10.024","volume":"55","author":"Granato D.","year":"2014","unstructured":"Granato D.; de Ara\u00fajo Calado V.M.; Jarvis B.; Observations on the use of statistical methods in Food Science and Technology. Food Res Int  2014,55,137-149","journal-title":"Food Res Int"},{"key":"ref=168","author":"Montgomery D.C.","year":"2020","unstructured":"Montgomery D.C.;  Introduction to Statistical Quality Control  2020","journal-title":"Introduction to Statistical Quality Control"},{"key":"ref=169","first-page":"157","author":"Ait-Amir B.","year":"2020","unstructured":"Ait-Amir B.; Pougnet P.; El Hami A.; Meta-model development. Embedded mechatronic systems 2  2020,157-187","journal-title":"Embedded mechatronic systems 2"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cem.2461","volume":"26","author":"Raki\u0107 T.","year":"2012","unstructured":"Raki\u0107 T.; Jan\u010di\u0107-Stojanovi\u0107 B.; Malenovi\u0107 A.; Ivanovi\u0107 D.; Medenica M.; Demasking large dummy effects approach in revealing important interactions in Plackett-Burman experimental design. J Chemometr  2012,26(10),518-525","journal-title":"J Chemometr"},{"key":"ref=171","unstructured":"Patents G. Patents Available from:  https:\/\/patents.google.com\/advanced"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230508121716","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216647\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230508121716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:10:26Z","timestamp":1713978626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216647\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":173,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230508121716","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}